Type 1 diabetes management: Room for improvement 1型糖尿病管理的改进空间

IF 3 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Rita D. M. Varkevisser, Erwin Birnie, Dick Mul, Peter R. van Dijk, Henk-Jan Aanstoot, Bruce H. R. Wolffenbuttel, Melanie M. van der Klauw
{"title":"Type 1 diabetes management: Room for improvement\n 1型糖尿病管理的改进空间","authors":"Rita D. M. Varkevisser,&nbsp;Erwin Birnie,&nbsp;Dick Mul,&nbsp;Peter R. van Dijk,&nbsp;Henk-Jan Aanstoot,&nbsp;Bruce H. R. Wolffenbuttel,&nbsp;Melanie M. van der Klauw","doi":"10.1111/1753-0407.13368","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims/Hypothesis</h3>\n \n <p>Optimal diabetes care and risk factor management are important to delay micro- and macrovascular complications in individuals with type 1 diabetes (T1D). Ongoing improvement of management strategies requires the evaluation of target achievement and identification of risk factors in individuals who do (or do not) achieve these targets.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Cross-sectional data were collected from adults with T1D visiting six diabetes centers in the Netherlands in 2018. Targets were defined as glycated hemoglobin (HbA1c) &lt;53 mmol/mol, low-density lipoprotein-cholesterol (LDL-c) &lt;2.6 mmoL/L (no cardiovascular disease [CVD] present) or &lt;1.8 mmoL/L (CVD present), or blood pressure (BP) &lt;140/90 mm Hg. Target achievement was compared for individuals with and without CVD.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Data from 1737 individuals were included. Mean HbA1c was 63 mmol/mol (7.9%), LDL-c was 2.67 mmoL/L, and BP 131/76 mm Hg. In individuals with CVD, 24%, 33%, and 46% achieved HbA1c, LDL-c, and BP targets respectively. In individuals without CVD these percentages were 29%, 54%, and 77%, respectively. Individuals with CVD did not have any significant risk factors for HbA1c, LDL-c, and BP target achievement. In comparison, individuals without CVD were more likely to achieve glycemic targets if they were men and insulin pump users. Smoking, microvascular complications, and the prescription of lipid-lowering and antihypertensive medication were negatively associated with glycemic target achievement. No characteristics were associated with LDL-c target achievement. Microvascular complications and antihypertensive medication prescription were negatively associated with BP target attainment.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Opportunities for improvement of diabetes management exist for the achievement of glycemic, lipid, and BP targets but may differ between individuals with and without CVD.</p>\n </section>\n </div>","PeriodicalId":189,"journal":{"name":"Journal of Diabetes","volume":"15 3","pages":"255-263"},"PeriodicalIF":3.0000,"publicationDate":"2023-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1753-0407.13368","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.13368","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 2

Abstract

Aims/Hypothesis

Optimal diabetes care and risk factor management are important to delay micro- and macrovascular complications in individuals with type 1 diabetes (T1D). Ongoing improvement of management strategies requires the evaluation of target achievement and identification of risk factors in individuals who do (or do not) achieve these targets.

Methods

Cross-sectional data were collected from adults with T1D visiting six diabetes centers in the Netherlands in 2018. Targets were defined as glycated hemoglobin (HbA1c) <53 mmol/mol, low-density lipoprotein-cholesterol (LDL-c) <2.6 mmoL/L (no cardiovascular disease [CVD] present) or <1.8 mmoL/L (CVD present), or blood pressure (BP) <140/90 mm Hg. Target achievement was compared for individuals with and without CVD.

Results

Data from 1737 individuals were included. Mean HbA1c was 63 mmol/mol (7.9%), LDL-c was 2.67 mmoL/L, and BP 131/76 mm Hg. In individuals with CVD, 24%, 33%, and 46% achieved HbA1c, LDL-c, and BP targets respectively. In individuals without CVD these percentages were 29%, 54%, and 77%, respectively. Individuals with CVD did not have any significant risk factors for HbA1c, LDL-c, and BP target achievement. In comparison, individuals without CVD were more likely to achieve glycemic targets if they were men and insulin pump users. Smoking, microvascular complications, and the prescription of lipid-lowering and antihypertensive medication were negatively associated with glycemic target achievement. No characteristics were associated with LDL-c target achievement. Microvascular complications and antihypertensive medication prescription were negatively associated with BP target attainment.

Conclusion

Opportunities for improvement of diabetes management exist for the achievement of glycemic, lipid, and BP targets but may differ between individuals with and without CVD.

Abstract Image

Type 1 diabetes management: Room for improvement 1型糖尿病管理的改进空间
目的/假设优化糖尿病护理和风险因素管理对于延迟1型糖尿病(T1D)患者的微血管和大血管并发症至关重要。管理策略的持续改进需要对目标实现情况进行评估,并确定实现(或未实现)这些目标的个人的风险因素。方法收集2018年在荷兰6个糖尿病中心就诊的成年T1D患者的横断面数据。目标定义为糖化血红蛋白(HbA1c)≤53 mmol/mol,低密度脂蛋白-胆固醇(LDL-c)≤2.6 mmol/ L(无心血管疾病)或≤1.8 mmol/ L(有心血管疾病),或血压≤140/90 mm Hg。比较有和无心血管疾病个体的目标实现情况。结果纳入了1737名个体的数据。平均HbA1c为63 mmol/mol (7.9%), LDL-c为2.67 mmol/ L,血压为131/76 mm Hg。在CVD患者中,分别有24%、33%和46%达到了HbA1c、LDL-c和BP目标。在没有心血管疾病的个体中,这一比例分别为29%、54%和77%。CVD患者在HbA1c、LDL-c和BP目标实现方面没有任何显著的危险因素。相比之下,没有心血管疾病的男性和胰岛素泵使用者更有可能达到血糖目标。吸烟、微血管并发症、降脂降压药物处方与血糖达标呈负相关。没有与LDL-c目标实现相关的特征。微血管并发症和抗高血压药物处方与血压目标达成呈负相关。结论:改善糖尿病管理的机会是存在的,可以达到血糖、血脂和血压目标,但在有和没有心血管疾病的个体之间可能存在差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Diabetes
Journal of Diabetes ENDOCRINOLOGY & METABOLISM-
CiteScore
6.50
自引率
2.20%
发文量
94
审稿时长
>12 weeks
期刊介绍: Journal of Diabetes (JDB) devotes itself to diabetes research, therapeutics, and education. It aims to involve researchers and practitioners in a dialogue between East and West via all aspects of epidemiology, etiology, pathogenesis, management, complications and prevention of diabetes, including the molecular, biochemical, and physiological aspects of diabetes. The Editorial team is international with a unique mix of Asian and Western participation. The Editors welcome submissions in form of original research articles, images, novel case reports and correspondence, and will solicit reviews, point-counterpoint, commentaries, editorials, news highlights, and educational content.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信